Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 5/2018

Open Access 01-10-2018 | Research Article

Filled prescriptions of age-related contraindicated drugs in children: a one-year nationwide cohort study in the Netherlands

Authors: K. Cheung, M. Teichert, H. A. Moll, B. H. Stricker, L. E. Visser

Published in: International Journal of Clinical Pharmacy | Issue 5/2018

Login to get access

Abstract

Background Children are still prescribed age contraindicated drugs, but information about the number and type of these drugs dispensed for children in the Netherlands is limited. Objective To determine the incidence and prevalence of contraindicated drugs that were dispensed for the use by children. Setting The study was conducted in the Netherlands with routinely collected data from 95% of all community pharmacies. Method We performed a one-year nationwide observational study where all patients aged 17 years or younger who have received at least one prescription in 2016 were included. Contraindicated drugs were selected, according to the 5th level of ATC code, using different information sources. Main outcome measure The proportion of (newly) contraindicated drugs that were dispensed to children. Results In total, 3.9% of all children received at least one drug that was contraindicated for their age. The highest percentage of contraindicated drugs that was dispensed, was observed in patients aged 1–2 years and 13–17 years (7.0 and 5.7%, respectively) and the percentage of contraindicated drugs that were dispensed was higher in female than in male patients (4.3 and 3.6%, respectively; p value < 0.001). Conclusion The results of this study show that a substantial percentage of children received a drug that was conta-indicated for their age, and it happes more in female than in male patients. Furthermore, the information about this type of contraindications is limited and inconsistent.
Literature
1.
go back to reference Impicciatore P, Choonara I, Clarkson A, Provasi D, Pandolfini C, Bonati M. Incidence of adverse drug reactions in paediatric in/out-patients: a systematic review and meta-analysis of prospective studies. Br J Clin Pharmacol. 2001;52(1):77–83.CrossRef Impicciatore P, Choonara I, Clarkson A, Provasi D, Pandolfini C, Bonati M. Incidence of adverse drug reactions in paediatric in/out-patients: a systematic review and meta-analysis of prospective studies. Br J Clin Pharmacol. 2001;52(1):77–83.CrossRef
2.
go back to reference Guideline on good pharmacovigilance practices (GVP) Annex I—Definitions (Rev 3). European Medicines Agency; 2014:14. Guideline on good pharmacovigilance practices (GVP) Annex I—Definitions (Rev 3). European Medicines Agency; 2014:14.
3.
go back to reference Starke PR, Weaver J, Chowdhury BA. Boxed warning added to promethazine labeling for pediatric use. N Engl J Med. 2005;352(25):2653.CrossRef Starke PR, Weaver J, Chowdhury BA. Boxed warning added to promethazine labeling for pediatric use. N Engl J Med. 2005;352(25):2653.CrossRef
4.
go back to reference Lenk C, Duttge G. Ethical and legal framework and regulation for off-label use: European perspective. Ther Clin Risk Manag. 2014;10:537–46.CrossRef Lenk C, Duttge G. Ethical and legal framework and regulation for off-label use: European perspective. Ther Clin Risk Manag. 2014;10:537–46.CrossRef
5.
go back to reference Aschenbrenner DS. Codeine and tramadol contraindicated for pediatric use. Am J Nurs. 2017;117(8):23.CrossRef Aschenbrenner DS. Codeine and tramadol contraindicated for pediatric use. Am J Nurs. 2017;117(8):23.CrossRef
6.
go back to reference Bensouda-Grimaldi L, Sarraf N, Doisy F, Jonville-Bera AP, Pivette J, Autret-Leca E. Prescription of drugs contraindicated in children: a national community survey. Eur J Clin Pharmacol. 2007;63(1):99–101.CrossRef Bensouda-Grimaldi L, Sarraf N, Doisy F, Jonville-Bera AP, Pivette J, Autret-Leca E. Prescription of drugs contraindicated in children: a national community survey. Eur J Clin Pharmacol. 2007;63(1):99–101.CrossRef
7.
go back to reference Guedon-Moreau L, Ducrocq D, Duc MF, Quieureux Y, L'Hôte C, Deligne J, Caron J. Absolute contraindications in relation to potential drug interactions in outpatient prescriptions: analysis of the first five million prescriptions in 1999. Eur J Clin Pharmacol. 2004;59(12):899–904.CrossRef Guedon-Moreau L, Ducrocq D, Duc MF, Quieureux Y, L'Hôte C, Deligne J, Caron J. Absolute contraindications in relation to potential drug interactions in outpatient prescriptions: analysis of the first five million prescriptions in 1999. Eur J Clin Pharmacol. 2004;59(12):899–904.CrossRef
8.
go back to reference Horen B, Montastruc JL, Lapeyre-Mestre M. Adverse drug reactions and off-label drug use in paediatric outpatients. Br J Clin Pharmacol. 2002;54(6):665–70.CrossRef Horen B, Montastruc JL, Lapeyre-Mestre M. Adverse drug reactions and off-label drug use in paediatric outpatients. Br J Clin Pharmacol. 2002;54(6):665–70.CrossRef
9.
go back to reference Tsai HH, Lin HW, Simon Pickard A, Tsai HY, Mahady GB. Evaluation of documented drug interactions and contraindications associated with herbs and dietary supplements: a systematic literature review. Int J Clin Pract. 2012;66(11):1056–78.CrossRef Tsai HH, Lin HW, Simon Pickard A, Tsai HY, Mahady GB. Evaluation of documented drug interactions and contraindications associated with herbs and dietary supplements: a systematic literature review. Int J Clin Pract. 2012;66(11):1056–78.CrossRef
10.
go back to reference Teichert M, Schermer T, van den Nieuwenhof L, De Smet PA, Wensing M. Prevalence of inappropriate prescribing of inhaled corticosteroids for respiratory tract infections in the Netherlands: a retrospective cohort study. NPJ Prim Care Respir Med. 2014;24:14086.CrossRef Teichert M, Schermer T, van den Nieuwenhof L, De Smet PA, Wensing M. Prevalence of inappropriate prescribing of inhaled corticosteroids for respiratory tract infections in the Netherlands: a retrospective cohort study. NPJ Prim Care Respir Med. 2014;24:14086.CrossRef
11.
go back to reference Methodology WCCfDS. Guidelines for ATC Classification and DDD Assignment 2016. Oslo, 2016. Methodology WCCfDS. Guidelines for ATC Classification and DDD Assignment 2016. Oslo, 2016.
14.
go back to reference Putignano D, Bruzzese D, Orlando V, Fiorentino D, Tettamanti A, Menditto E. Differences in drug use between men and women: an Italian cross sectional study. BMC Womens Health. 2017;17(1):73.CrossRef Putignano D, Bruzzese D, Orlando V, Fiorentino D, Tettamanti A, Menditto E. Differences in drug use between men and women: an Italian cross sectional study. BMC Womens Health. 2017;17(1):73.CrossRef
15.
go back to reference Verbrugge LM. How physicians treat mentally distressed men and women. Soc Sci Med. 1984;18(1):1–9.CrossRef Verbrugge LM. How physicians treat mentally distressed men and women. Soc Sci Med. 1984;18(1):1–9.CrossRef
16.
go back to reference Verbrugge LM, Steiner RP. Prescribing drugs to men and women. Health Psychol. 1985;4(1):79–98.CrossRef Verbrugge LM, Steiner RP. Prescribing drugs to men and women. Health Psychol. 1985;4(1):79–98.CrossRef
17.
go back to reference Regitz-Zagrosek V. Sex and gender differences in health. Science and Society Series on Sex and Science. EMBO Rep. 2012;13(7):596–603.CrossRef Regitz-Zagrosek V. Sex and gender differences in health. Science and Society Series on Sex and Science. EMBO Rep. 2012;13(7):596–603.CrossRef
18.
go back to reference Taylor PN, Davies JS. A review of the growing risk of vitamin D toxicity from inappropriate practice. Br J Clin Pharmacol. 2018. Taylor PN, Davies JS. A review of the growing risk of vitamin D toxicity from inappropriate practice. Br J Clin Pharmacol. 2018.
19.
go back to reference Weinstein RB, Fife D, Sloan S, Voss EA, Treem W. Prevalence of chronic metoclopramide use and associated diagnoses in the US pediatric population. Paediatr Drugs. 2015;17(4):331–7.CrossRef Weinstein RB, Fife D, Sloan S, Voss EA, Treem W. Prevalence of chronic metoclopramide use and associated diagnoses in the US pediatric population. Paediatr Drugs. 2015;17(4):331–7.CrossRef
21.
go back to reference Gaillard T, Briolant S, Madamet M, Pradines B. The end of a dogma: the safety of doxycycline use in young children for malaria treatment. Malar J. 2017;16(1):148.CrossRef Gaillard T, Briolant S, Madamet M, Pradines B. The end of a dogma: the safety of doxycycline use in young children for malaria treatment. Malar J. 2017;16(1):148.CrossRef
22.
go back to reference Donovan BJ, Weber DJ, Rublein JC, Raasch RH. Treatment of tick-borne diseases. Ann Pharmacother. 2002;36(10):1590–7.CrossRef Donovan BJ, Weber DJ, Rublein JC, Raasch RH. Treatment of tick-borne diseases. Ann Pharmacother. 2002;36(10):1590–7.CrossRef
23.
go back to reference Todd SR, Dahlgren FS, Traeger MS, Beltrán-Aquilar ED, Marianos DW, Hamilton C, McQuiston JH, Regan JJ. No visible dental staining in children treated with doxycycline for suspected Rocky Mountain Spotted Fever. J Pediatr. 2015;166(5):1246–51.CrossRef Todd SR, Dahlgren FS, Traeger MS, Beltrán-Aquilar ED, Marianos DW, Hamilton C, McQuiston JH, Regan JJ. No visible dental staining in children treated with doxycycline for suspected Rocky Mountain Spotted Fever. J Pediatr. 2015;166(5):1246–51.CrossRef
24.
go back to reference Volovitz B, Shkap R, Amir J, Calderon S, Varsano I, Nussinovitch M. Absence of tooth staining with doxycycline treatment in young children. Clin Pediatr (Phila). 2007;46(2):121–6.CrossRef Volovitz B, Shkap R, Amir J, Calderon S, Varsano I, Nussinovitch M. Absence of tooth staining with doxycycline treatment in young children. Clin Pediatr (Phila). 2007;46(2):121–6.CrossRef
Metadata
Title
Filled prescriptions of age-related contraindicated drugs in children: a one-year nationwide cohort study in the Netherlands
Authors
K. Cheung
M. Teichert
H. A. Moll
B. H. Stricker
L. E. Visser
Publication date
01-10-2018
Publisher
Springer International Publishing
Published in
International Journal of Clinical Pharmacy / Issue 5/2018
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-018-0717-6

Other articles of this Issue 5/2018

International Journal of Clinical Pharmacy 5/2018 Go to the issue